Workshop on making Article 58 and other European Medicines Agency outputs more relevant for non-EU regulators

• Date:
  Thursday, 2 March 2017, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

Access to medicines is an issue for patients across the world and the ability to assess and supervise medicines once in use are common issues facing public health authorities and regulators in all parts of the world. It was with this in mind that the European Medicines Agency (EMA), working together with the Maltese presidency of the European Union, brought together regulators from across EU and Africa in Malta on 2 and 3 March 2017 to discuss EMA procedures and role in facilitating access. The meeting was attended by EMA CHMP members, experts and staff, and African national regulatory authorities, the African Union NEPAD agency, and World Health Organization, the World Bank. The workshop was organised with the financial support of the Bill & Melinda Gates Foundation.

Documents

Workshop report - Making Article 58 and other European Medicines Agency outputs more relevant for non-EU regulators

Reference Number: EMA/184549/2017 Summary:

Access to medicines is an issue for patients across the world and the ability to assess and supervise

medicines once in use are common issues facing public health authorities and regulators in all parts of

the world. It was with this in mind that the European Medicines Agency (EMA), working together with

the Maltese presidency of the European Union, brought together regulators from across EU and Africa

in Malta on 2 and 3 March 2017 to discuss EMA procedures and role in facilitating access.